moleculight.comMolecuLight Inc | Advanced Wound Care Solutions

Start Seeing Wounds in a New Light ™ Start Seeing Wounds in a New Light ™ Solutions Solutions The MolecuLight i: X and DX for point-of-care detection of elevated bacterial burden in wounds – in real-time MolecuLight DX MolecuLight i: X Intro to the i: X How does Fluorescence Imaging Work Detection of Bacterial Burden Detectable Species BiofilmDigital Wound Area Measurement EMR Integration Telemedicine Solution MolecuLight Procedure i: X Workflow Image Interpretation Preview the MolecuLight i: X Intro to the i: X Workflow Image Atlas Product Suite MolecuLight DX Device MolecuLight i: X Device Accessories DarkDrape WoundStickers i: X Sterile Surgical Sleeve Wound Care Professionals Wound Care Professionals Research has shown how use of the MolecuLight i: X can inform clinical decision-making to improve wound healing rates Cost Savings Improved Outcomes Reimbursement Training & Education eLearning DX Training Videos i: X Training Videos Manuals & Quick Start Guide Continuing Medical Education Clinical Research Patients Resources Resources See the latest publication on how use of MolecuLight i: X can inform clinical decision-making to improve wound healing rates Latest Clinical Evidence All Evidence Accelerated Wound Healing Acute Wounds Advanced Therapies Anti-Microbial Stewardship Species Detected/Biofilm Burns Chronic Wounds Cost-Savings/ Reimbursement Detection of Bacterial Burden Diagnostic Accuracy Digital Wound Measurement Debridement/Wound Hygiene Pre-Clinical Applications Treatment Planning Wound Sampling Webcasts Video Master Series Image Atlas Training & Education eLearning DX Training Videos i: X Training Videos Manuals & Quick Start Guide See the latest press releases, events and updates from MolecuLight About MolecuLight Management Team Press Releases Conferences & Events Careers Contact MolecuLight Distributors Request A Demo Request A Demo Contact Us Contact Us Get in touch with MolecuLight or directly with our Global Distributors. Contact MolecuLight Distributors Search Quick links: MolecuLight i:X Digital Measurement of Wound Area Latest Clinical Evidence Latest news Phone: +1-877-818-4360 ROW Advanced Wound Care Device for Diagnostic Imaging MolecuLight i:X ® & DX ™ FDA CLEARED Introducing Point-of-Care Imaging for Wound Care The leading point-of-care wound imaging devices for the detection of the presence and location of elevated bacterial loads and for accurate digital wound measurement . Request A Quote Learn how they work: i: X DX Previous Next MolecuLight was recently featured in: MolecuLight i: X & DX may help at every stage of wound care Assessment Cleaning Debridement Sampling Documentation Treatment Selection Antibiotic Stewardship Patient Engagement Assessment Visualize fluorescent bacteria and measure wound surface area in real-time to understand the status of the wound more fully. 1,3 Cleaning Allows clinicians to focus cleaning in areas where fluorescent bacteria are located and optimize wound bed preparation. 10 Debridement Guides more efficient and targeted debridement. 2,6,7 Sampling Guides where to sample; 54% more accurate swabbing compared to the Levine technique. 3 Documentation Provides objective visual documentation of the presence of fluorescent bacteria and the surface area of the wound. 2,9 Treatment Selection Comparing fluorescent bacteria and wound surface area at each visit may provide real-time objective feedback on impact of treatment plan. 1,2,4 Antibiotic Stewardship Supports more responsible antibiotic decision making and selection. 6,8,9 Patient Engagement Patients easily see and understand why a clinician is taking certain action to clean, debride, and treat a wound in a specific way. 4,5 Assessment Visualize fluorescent bacteria and measure wound surface area in real-time to understand the status of the wound more fully. 1,3 Cleaning Allows clinicians to focus cleaning in areas where fluorescent bacteria are located and optimize wound bed preparation. 10 Debridement Guides more efficient and targeted debridement. 2,6,7 Sampling Guides where to sample; 54% more accurate swabbing compared to the Levine technique. 3 Documentation Provides objective visual documentation of the presence of fluorescent bacteria and the surface area of the wound. 2,9 Treatment Selection Comparing fluorescent bacteria and wound surface area at each visit may provide real-time objective feedback on impact of treatment plan. 1,2,4 Antibiotic Stewardship Supports more responsible antibiotic decision making and selection. 6,8,9 Patient Engagement Patients easily see and understand why a clinician is taking certain action to clean, debride, and treat a wound in a specific way. 4,5 Watch MolecuLight i: X in action The MolecuLight i: X Wound Imaging Device allows clinicians to quickly, safely, and easily visualize bacteria 2 and measure wounds 7 at the point of care, so they have maximum insights for accurate treatment selection and accelerated healing. New peer-reviewed publications featuring MolecuLight appeared in: View All Publications Featuring MolecuLight CASE STUDY Real-Time Detection of Asymptomatic Bioburden in Wounds Use of the MolecuLight i: X to image for bacterial fluorescence, in conjunction with clinical signs & symptoms, adds an additional bacterial-specific piece of information that can be captured and considered in real-time. See Full Case Study Testimonials "The MolecuLight i: X has transformed my clinical decision making. MolecuLight i: X helps reveal the unexpected and eliminates guess work." Rosemary Hill, BSN CWOCN CETN(C) // Vancouver Coastal Health, North Vancouver, Canada "The MolecuLight i: X completely changed my decision making and resulted in not only time and cost savings but also improved patient outcomes.” Lt Col Steven Jeffery // The Royal Centre for Defence Medicine, Birmingham, UK "The MolecuLight i: X gives clinicians the ability to visualize and therefore target treatment towards clinically undetectable critical colonization. This user friendly point-of-care device is an exciting addition to our wound care protocol." David Russell, MD // Leeds Teaching Hospitals, Leeds, UK Welcome to MolecuLight Please select where you are from to see the most relevant information USA Rest of World Find out how to make a difference in wound care Request Information Request Demo Request Quote Stay on top of the latest advancements in wound care Follow us on Follow Us on Updates from Twitter ; MolecuLight Inc. @moleculight · 27 Nov 1729080759938580901 Love this reminder of where @moleculight started out. Thank you, @DGArmstrong Reply on Twitter 1729080759938580901 Retweet on Twitter 1729080759938580901 0 Like on Twitter 1729080759938580901 1 Twitter 1729080759938580901 ; MolecuLight Inc. @moleculight · 21 Nov 1726922199632957511 PRESS RELEASE: United States Patent and Trademark Office (USPTO) Cancels All Claims of Swift Medical’s Patent. @moleculight Victorious in its Efforts to Prove Swift Medical Did Not Merit a Patent https://tinyurl.com/2p8naafn Twitter feed image. Reply on Twitter 1726922199632957511 Retweet on Twitter 1726922199632957511 0 Like on Twitter 1726922199632957511 1 Twitter 1726922199632957511 ; MolecuLight Inc. @moleculight · 20 Nov 1726595807498121332 Hear Joe McClung (FloodGate Medical) profile @moleculight and Martha Yannessa in his Symposium on Advanced Wound Care (SAWC) Fall 2023 Buzz Report Twitter feed video. Reply on Twitter 1726595807498121332 Retweet on Twitter 1726595807498121332 0 Like on Twitter 1726595807498121332 0 Twitter 1726595807498121332 ; MolecuLight Inc. @moleculight · 20 Nov 1726570049086034391 Submit your abstract for for @EWMA 2024 showing the utility and clinical outcomes with your @moleculight deviceand present your work at Europe’s largest wound care conference. Abstract submission deadline is 6 December, 2023 at 23:59 CET https://tinyurl.com/3khju8r7 Twitter feed image. Reply on Twitter 1726570049086034391 Retweet on Twitter 1726570049086034391 0 Like on Twitter...